From: Therapeutic efficacy of sorafenib and plant-derived phytochemicals in human colorectal cancer cells
Single and combined treatment with Sora and Cur or Kmf | SW1116 | SW837 | ||||
---|---|---|---|---|---|---|
A. Single and combined treatment with Sora and Cur. | IC-values (µM) | SR | P-value | IC-values (µM) | SR | P-value |
1. Sequential treatment with Sora and Cur: Sora (24Â h) followed by Cur (48Â h) | ||||||
 a. Sora (0.25- 10 µM) | IC60 = 7.70 | N.A | - | IC70 = 0.86 | N.A | - |
 b. Sora (0.25- 10 µM) + Cur (60 µM) | IC60 = 9.14 | 0.843 | 0.307 | IC70 = 0.86 | 1.00 | 0.993 |
 c. Sora (0.25- 10 µM) + Cur (120 µM) | IC60 = 4.00 | 1.925 | 0.006 | IC70 = 0.57 | 1.51 | 0.457 |
2. Inverted sequential treatment with Sora and Cur: Cur (24Â h) followed by Sora (48Â h) | ||||||
 a. Sora (0.25- 10 µM) | IC70 = 6.00 | N.A | - | IC60 = 8.00 | N.A | 0.081 vs. b 0.001 vs. c |
 b. Sora (0.25- 10 µM) + Cur (60 µM) | IC70 = 6.86 | 0.880 | 0.504 | N.D | N.D | b |
 c. Sora (0.25- 10 µM) + Cur (120 µM | IC70 = 4.86 | 1.240 | 0.504 | IC60 = 2.00 | 4.00 | c |
3. Simultaneous treatment with Sora and Cur: (72Â h) | ||||||
 a. Sora (0.25- 10 µM) | IC80 = 4.86 | N.A | - | IC60 = 7.43 | N.A | 0.019 vs. b 0.027 vs. c |
 b. Sora (0.25- 10 µM) + Cur (60 µM) | IC80 = 0.57 | 8.530 | 0.136 | N.D | N.D | b |
 c. Sora (0.25- 10 µM) + Cur (120 µM | IC80 = 0.57 | 8.530 | 0.088 | N.D | N.D | c |
B. Single and combined treatment with Sora and Kmf | IC-values (µM) | SR | P- value | IC-values (µM) | SR | P-value |
1. Sequential treatment with Sora and Kmf: Sora (24Â h) followed by Kmf (48Â h) | ||||||
 a. Sora (0.25- 10 µM) | IC60 = 0.57 | N.A | - | IC60 = 7.43 | N.A | 0.716 vs. b |
 b. Sora (0.25- 10 µM) + Kmf (60 µM) | IC60 = 1.14 | 0.500 | 0.560 | IC60 = 9.43 | 0.79 | b |
 c. Sora (0.25- 10 µM) + Kmf (120 µM) | IC60 = 1.14 | 0.500 | 0.675 | IC60 = 6.86 | 1.08 | 0.214 |
2. Inverted sequential treatment with Sora and Kmf: Kmf (24Â h) followed by Sora (48Â h) | ||||||
 a. Sora (0.25- 10 µM) | IC60 = 4.86 | N.A | - | IC60 = 7.43 | N.A | 0.010 vs. b 0.008 vs. c |
 b. Sora (0.25- 10 µM) + Kmf (60 µM) | IC60 = 4.00 | 1.22 | 0.148 | N.D | N.D | b |
 c. Sora (0.25- 10 µM) + Kmf (120 µM) | IC60 = 2.00 | 2.43 | 0.134 | N.D | N.D | c |
3. simultaneous treatment with Sora and Kmf: (72Â h) | ||||||
 a. Sora (0.25- 10 µM) | IC80 = 4.86 | N.A | - | IC60 = 7.14 | N.A | 0.009 vs. b 0.013 vs. c |
 b. Sora (0.25- 10 µM) + Kmf (60 µM) | IC80 = 0.57 | 8.53 | 0.513 | N.D | N.D | b |
 c. Sora (0.25- 10 µM) + Kmf (120 µM) | IC80 = 0.57 | 8.53 | 0.152 | N.D | N.D | c |